参考文献: [1]NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®), Breast Cancer, Version 6.2024, November 11, 2024. [2]Turner NC, Im SA, Saura C, et al. Inavolisib-Based Therapy in PIK3CA-Mutated Advanced Breast...
[1]NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®), Breast Cancer, Version 6.2024, November 11, 2024. [2]Turner NC, Im SA, Saura C, et al. Inavolisib-Based Therapy in PIK3CA-Mutated Advanced Breast Cancer. N Engl J Med. 2024 Oct 31;391(17):1584-1596. 精彩资讯等...
1.NCCN. Clinical Practice Guidelines in Oncology. Breast cancer, version 6.2024. Accessed November 21, 2024. https://www.nccn.org/professionals/physician_gls/pdf/breast.pdf 2.Novartis ribociclib (Kisqali®) recognized as Category...